Design Therapeutics, Inc. (DSGN)
USD 5.95
(-4.8%)
USD 5.95
(-4.8%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | 226.00 | 834.00 |
| Cost of Revenue | 537 Thousand | 466 Thousand | 129 Thousand | 5000.00 | 1654.00 |
| Gross Profit | -537 Thousand | -466 Thousand | -129 Thousand | -4774.00 | -820.00 |
| Operating Expenses | 78.19 Million | 67.59 Million | 35.83 Million | 8.33 Million | 1.9 Million |
| Selling, General and Administrative Expenses | 21.12 Million | 18.98 Million | 11.05 Million | 2.49 Million | 1.08 Million |
| Research and Development Expenses | 57.06 Million | 48.61 Million | 24.77 Million | 6.06 Million | 1.65 Million |
| Other Expenses | - | 4.28 Million | 298 Thousand | -226 Thousand | -834 Thousand |
| Cost and Expenses | 78.19 Million | 67.59 Million | 35.83 Million | 8.33 Million | 1.9 Million |
| Operating Income | -78.19 Million | -67.59 Million | -35.83 Million | -8.33 Million | -1.9 Million |
| Interest Expense | - | - | - | - | - |
| Income Tax Expense | -1.00 | -4.69 Million | -107.55 Thousand | -201.29 Thousand | -1908.00 |
| Earnings before Tax | -66.86 Million | -63.3 Million | -35.53 Million | -8.28 Million | -2.04 Million |
| Net Income | -66.86 Million | -58.61 Million | -35.53 Million | -8.28 Million | -2.04 Million |
| Earnings Per Share Basic | -1.19 | -1.05 | -0.77 | -0.30 | -0.08 |
| Earnings Per Share Diluted | -1.19 | -1.05 | -0.77 | -0.30 | -0.08 |
| Weighted Average Shares Outstanding | 55.98 Million | 55.7 Million | 45.94 Million | 27.19 Million | 27.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 55.98 Million | 55.7 Million | 45.94 Million | 27.19 Million | 27.19 Million |
| Gross Margin | - | - | - | -21.12 | -0.98 |
| EBIT Margin | - | - | - | -36.83 Thousand | -2287.77 |
| Profit Margin | - | - | - | -36.63 Thousand | -2454.44 |
| EBITDA | -66.32 Million | -62.84 Million | -35.7 Million | -8.32 Million | -139 Thousand |
| Earnings Before Tax Margin | - | - | - | -36.85 Thousand | -2287.77 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 838 Thousand | - | - | - |
| Cost of Revenue | 151 Thousand | 143 Thousand | 138 Thousand | 537 Thousand | 137 Thousand | 143 Thousand |
| Gross Profit | -151 Thousand | -143 Thousand | 700 Thousand | -537 Thousand | -137 Thousand | -143 Thousand |
| Operating Expenses | 14.89 Million | 14.25 Million | 14.98 Million | 78.19 Million | 18.82 Million | 22.59 Million |
| Selling, General and Administrative Expenses | 4.52 Million | 4.59 Million | 4.1 Million | - | 5.56 Million | 5.53 Million |
| Research and Development Expenses | 10.36 Million | 9.65 Million | 10.87 Million | - | 13.25 Million | 17.06 Million |
| Other Expenses | 3.25 Million | 3.29 Million | 3.27 Million | - | 3.03 Million | 2.65 Million |
| Cost and Expenses | 15.04 Million | 14.4 Million | 15.12 Million | 78.19 Million | 18.82 Million | 22.59 Million |
| Operating Income | -15.04 Million | -14.4 Million | -15.12 Million | -78.19 Million | -18.82 Million | -22.59 Million |
| Interest Expense | - | - | 129 Thousand | - | - | - |
| Income Tax Expense | - | 99.72 Thousand | 2.49 Million | -537 Thousand | -137 Thousand | 10.91 Thousand |
| Earnings before Tax | -11.79 Million | -11.1 Million | -11.84 Million | -66.86 Million | -15.78 Million | -19.93 Million |
| Net Income | -11.79 Million | -11.1 Million | -11.84 Million | -66.86 Million | -15.78 Million | -19.93 Million |
| Earnings Per Share Basic | -0.21 | -0.20 | -0.21 | - | -0.28 | -0.36 |
| Earnings Per Share Diluted | -0.21 | -0.20 | -0.21 | - | -0.28 | -0.36 |
| Weighted Average Shares Outstanding | 56.55 Million | 56.48 Million | 56.15 Million | 55.98 Million | 55.98 Million | 55.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 56.55 Million | 56.48 Million | 56.15 Million | 55.98 Million | 55.98 Million | 55.94 Million |
| Gross Margin | - | - | 0.84 | - | - | - |
| EBIT Margin | - | - | -17.88 | - | - | - |
| Profit Margin | - | - | -14.13 | - | - | - |
| EBITDA | -14.89 Million | -14.25 Million | -14.98 Million | - | -18.82 Million | -22.46 Million |
| Earnings Before Tax Margin | - | - | -18.04 | - | - | - |
GMS
3302
6393
NAHARCAP
7823
VVX